Cell-cycle analysis for mouse melanomas indicated that IFN-β treatment could induce 72.4% tumor cells into the state of G0/G1 arrest, compared with 20.5% quiescent tumor cells from the control group, suggesting that IFN-β could induce melanoma cells into dormancy. The gene discussed is IFNB1; the disease is melanoma.